The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1
Abstract
Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant disorder characterized by neurodegeneration of the cerebellum, spinal cord and brainstem. A 1.2-Megabase stretch of DNA from the short arm of chromosome 6 containing the SCA1 locus was isolated in a yeast artificial chromosome contig and subcloned into cosmids. A highly polymorphic CAG repeat was identified in this region and was found to be unstable and expanded in individuals with SCA1. There is a direct correlation between the size of the (CAG)n repeat expansion and the age-of-onset of SCA1, with larger alleles occurring in juvenile cases. We also show that the repeat is present in a 10 kilobase mRNA transcript. SCA1 is therefore the fifth genetic disorder to display a mutational mechanism involving an unstable trinucleotide repeat.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“spinocerebellar ataxia type 1 (SCA1), a disease caused by a polyglutamine expansion in the protein ATAXIN1 (ATXN1).”
From Polyglutamine Disease Toxicity Is Regulated by Nemo-like Kinase in Spinocerebellar Ataxia Type 1 (2013) · cites this paper as Orr et al., 1993
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481
Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Pieretti, M., Sutcliffe, J. S., Richards, S., Verkert, A. J. M. H., Holden, J. J. A., Fenwick, R. G., Warren, S. T., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90283-5 · Cited by 2,080
Flagged first, then by citations
Research works printed but not linked: 40
- Schut, J.W. Hereditary ataxia: clinical study through six generations. Arch. Neurol. Psychiat. 63, 535–567 (1954). · DOI
- Currier, R.D., Glover, G., Jackson, J.F. & Tipton, A.C. Spinocerebellar ataxia: study of a large kindred. Neurology 22, 1040–1043 (1972). · DOI
- Nino, H.E., Noreen, H.J. & Dubey, D.P. A family with hereditary ataxia: HLA typing. Neurology 30, 12–20 (1980). · DOI
- Zoghbi, H.Y. et al. Spinocerebellar ataxia: variable age of onset and linkage to human leukocyte antigen in a large kindred. Ann. Neurol. 23, 580–584 (1988). · DOI
- Greenfield, J.G. The spino-cerebellar degenerations (Charles C. Thomas, Springfield, Illinois, 1954).
- Haines, J.L., Schut, L.J. & Weitkamp, L.R. Spinocerebellar ataxia in large kindred: age at onset, reproduction, and genetic linkage studies. Neurology 34, 1542–1548 (1984). · DOI
- Brook, J.D. et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68, 799–808 (1992). · DOI
- Bruner, H.G. et al. Reverse mutation in myotonic dystrophy. New Engl. J. Med. 328, 476–480 (1993). · DOI
- Buxton, J. et al. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature 355, 547–548 (1992). · DOI
- Fu, Y.-H. et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255, 1256–1259 (1992). · DOI
- Harley, H.G. et al. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 355, 545–546 (1992). · DOI
- Harley, H.G. et al. Unstable DNA sequence in myotonic dystrophy. Lancet 339, 1125–1128 (1992). · DOI
- Kremer, E.J. et al. Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science 252, 1711–1714 (1991). · DOI
- Mahadevan, M. et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science 255, 1253–1255 (1992). · DOI
- La Spada, A.R., Wilson, E.M., Lubahn, D.B., Harding, A.E. & Fishbeck, K.H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352, 77–79 (1991). · DOI
- Yakura, H., Wakisaka, A., Fujimoto, S. & Itakura, K. Hereditary ataxia and HLA genotypes. New Engl. J. Med. 291, 154–155 (1974).
- Jackson, J.F., Currier, R.D., Terasaki, P.I. & Morton, N.E. Spinocerebellar ataxia and HLA linkage: risk prediction by HLA typing. New Engl. J. Med. 296, 1138–1141 (1977). · DOI
- Ranum, L.P.W. et al. Localization of the autosomal dominant, HLA-linked spinocerebellar ataxia (SCA1) locus in two kindreds within an 8cM subregion of chromosome 6p. Am. J. hum. Genet. 49, 31–41 (1991).
- Kwiatkowski, T.J. Jr. et al. The gene for autosomal dominant spinocerebellar ataxia (SCA1) maps centromeric to D6S89 and shows no recombination, in nine large kindreds, with a dinudeotide repeat at the AM10 locus. Am. J. hum. Genet. (in the press).
- La Spada, A.R. et al. Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy. Nature Genet. 2, 301–304 (1992). · DOI
- Coutinho, P. & Andrade, C. Autosomal dominant system degeneration in Portuguese families of the Azores. Neurology 28, 703–709 (1978). · DOI
- Takiyama, Y. et al. The gene for Machado-Joseph disease maps to human chromosome 14q. Nature Genet. 4, 300–304 (1993). · DOI
- Harding, A.E. Genetic aspects of autosomal dominant late onset cerebellar ataxia. J. med. Genet. 18, 436–441 (1981). · DOI
- Orozco, G. et al. Dominantly inherited olivopontocerebellar atrophy from eastern Cuba: clinical, neuropathological, and biochemical findings. J. neurol. Sci. 93, 27–50 (1989). · DOI
- Gispert, S. et al. Chromosomal assignment of the second (Cuban) locus for autosomal dominant cerebellar atrophy (SCA2) to human chromosome 12q23–24.1. Nature Genet. 4, 295–299 (1993). · DOI
- Richards, R.I. et al. Evidence of founder chromosomes in fragile X syndrome. Nature Genet. 1, 257–260 (1992). · DOI
- Harley, H.G. et al. Detection of linkage disequilibrium between the myotonic dystrophy locus and a new polymorphic DNA marker. Am. J. hum. Genet 49, 68–75 (1991).
- Quigley, C.A. et al. Complete deletion of the androgen receptor gene: definion of the null phenotype of the androgen insensitivity syndrome and determination of carrier status. J. clin. endocrinol. Metab. 74, 927–933 (1992). · DOI
- Trifiro, M. et al. The 56/58 kDa androgen-binding protein in male genital skin fibroblasts with a deleted androgen receptor gene. Molec. cell. endocrinol. 75, 37–47 (1991). · DOI
- Wharton, K.A., Johansen, K.M., Xu, T. & Artavanis-Tsakonas, S. Nucleotide sequence from the neurogenic locus notch implies a gene product that shares homology with proteins containing EGF-like repeats. Cell 43, 567–581 (1985). · DOI
- Vaessin, H. et al. prospero is expressed in neuronal precursors and encodes a nuclear protein that is involved in the control of axonal outgrowth in Drosophila. Cell 67, 941–953 (1991). · DOI
- Bellen, H.J., Kooyer, S., D'Evelyn, D. & Pearlman, J. The Drosophila Couch potato protein is expressed in nuclei of peripheral neuronal precursors and shows homology to RNA-binding proteins. Genes Dev. 6, 2125–2136 (1992). · DOI
- Courey, A.J., Holtzman, D.A., Jackson, S.P. & Tjian, R. Synergistic activation by the glutamine-rich domains of human transcription factor Sp1. Cell 59, 827–836 (1989). · DOI
- Benson, M. & Pirrotta, V. The Drosophila zeste protein binds cooperatively to sites in many gene regulatory regions: implications for transvection and gene regulation. EMBO J. 7, 3907–3915 (1988). · DOI
- Rich, S.S., Wilkie, P., Schut, L., Vance, G. & Orr, H.T. Spinocerebellar ataxia: localization of an autosomal dominant locus between two markers on human chromosome 6. Am. J. hum. Genet. 41, 524–531 (1987).
- Zoghbi, H.Y., Daiger, S.P., McCall, A., O'Brien, W.E. & Beaudet, A.L. Extensive DNA polymorphism at the factor Xllla (F13a) locus and linkage to HLA. Am. J. hum. Genet. 42, 877–883 (1988).
- Sambrook, J., Fritsch, E.F. & Maniatis, T. Molecular Cloning: A Laboratory Manual 2nd edn (Cold Spring Harbor Laboratory Press, New York, 1989).
- Weissenbach, J. et al. A second-generation linkage map of the human genome. Nature 359, 794–801 (1992). · DOI
- Albertsen, H.M. et al. Construction and characterization of a yeast artificial chromosome library containing seven haploid human genome equivalents. Proc. natn. Acad. Sci. U.S.A. 87, 4256–4260 (1990). · DOI
- Brownstein, B.H. et al. Isolation of single-copy human genes from a library of yeast artificial chromosome clones. Science 244, 1348–1351 (1989). · DOI
Cited by
Sorted by citations
Items 101–200 of 1,000
Incidence of dominant spinocerebellar and Friedreich triplet repeats among 361 ataxia families
Moseley, M. L., Benzow, K. A., Schut, L., Bird, T., Gómez, C. M., Barkhaus, P. E., Blindauer, K., Labuda, M., Pandolfo, M., Koob, M. D., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1666 · Cited by 230
Self-citationZoghbi, H. Y., & Orr, H. T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800041200 · Cited by 229
Self-citationMice Lacking Ataxin-1 Display Learning Deficits and Decreased Hippocampal Paired-Pulse Facilitation
Matilla‐Dueñas, A., Roberson, E. D., Banfi, S., Morales, J., Armstrong, D. L., Burright, E. N., Orr, H. T., Sweatt, J. D., Zoghbi, H. Y., & Matzuk, M. M. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-14-05508.1998 · Cited by 223
“The genetic basis of SCA1 involves an expansion of an unstable CAG trinucleotide repeat located within the coding region of the SCA1 gene (Orr et al., 1993; Banfi et al., 1994).”
BackgroundSelf-citationHuman genetic diseases due to codon reiteration: Relationship to an evolutionary mechanism
Green, H. (1993) · Cell · doi:10.1016/0092-8674(93)90718-6 · Cited by 210
Histone deacetylase inhibitors as therapeutics for polyglutamine disorders
Butler, R. K., & Bates, G. P. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn1989 · Cited by 215
Evidence for postjunctional serotonin (5‐HT1) receptors in the trigeminocervical complex
Goadsby, P. J., Akerman, S., & Storer, R. (2001) · Annals of Neurology · doi:10.1002/ana.10066 · Cited by 217
Glutamine repeats and inherited neurodegenerative diseases: molecular aspects
Perutz, M. F. (1996) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(96)80016-9 · Cited by 204
Takano, H., Cancel‐Tassin, G., Ikeuchi, T., Lorenzetti, D., Mawad, R., Stévanin, G., Didierjean, O., Dürr, A., Oyake, M., Shimohata, T., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/302067 · Cited by 212
“Although classification of dominant SCAs on the basis of clinical presentation has been quite controversial, because of the overlap in clinical presentations among these SCAs, identification of the causative genes for SCA type 1 (SCA1 [MIM 164400]) (Orr et al. 1993), SCA type 2 (SCA2 [MIM 183090]) (Imbert et al.”
BackgroundMethodSelf-citationA cellular model that recapitulates major pathogenic steps of Huntington's disease
Lunkes, A. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.9.1355 · Cited by 190
Androgen Receptor Polymorphisms (CAG Repeat Lengths) in Androgenetic Alopecia, Hirsutism, and Acne
Sawaya, M. E., & Shalita, A. R. (1998) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/120347549800300103 · Cited by 211
Simple repetitive DNA sequences from primates: Compilation and analysis
Jurka, J., & Pethiyagoda, C. L. (1995) · Journal of Molecular Evolution · doi:10.1007/bf00167107 · Cited by 237
“…(Brook et al. 1992; Fu et al. 1992; Mahadevan et al. 1992); and CAG to Kennedy's disease (La Spada et al. 1991), spinocerebellar ataxia type 1 (Orr et al. 1993), Huntington's disease (Huntington's disease Collaborative Research Group 1993), and dentatorubral-pallidoluysian atrophy, or DRPLA…”
BackgroundNagafuchi, S., Yanagisawa, H., Ohsaki, E., Shirayama, T., Tadokoro, K., Inoue, T., & Yamada, M. (1994) · Nature Genetics · doi:10.1038/ng1094-177 · Cited by 202
miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis
Lee, Y., Samaco, R. C., Gatchel, J. R., Christina Thaller, B., Orr, H. T., & Zoghbi, H. Y. (2008) · Nature Neuroscience · doi:10.1038/nn.2183 · Cited by 201
Self-citationSpinocerebellar ataxia type 6: genotype and phenotype in German kindreds
Schöls, L., Krüger, R., Amoiridis, G., Przuntek, H., Epplen, J., & Riess, O. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.1.67 · Cited by 207
Timchenko, L., Timchenko, N. A., Caskey, C. T., & Roberts, R. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.1.115 · Cited by 198
RNA pathogenesis of the myotonic dystrophies
Day, J., & Ranum, L. P. W. (2004) · Neuromuscular Disorders · doi:10.1016/j.nmd.2004.09.012 · Cited by 190
“[5] Orr HT, Chung M-y, Banfi S, et al.”
BackgroundSelf-citationThe Unstable Repeats—Three Evolving Faces of Neurological Disease
Nelson, D. L., Orr, H. T., & Warren, S. T. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.022 · Cited by 207
“Subsequent to cloning the SCA1 gene (Orr et al., 1993), studies identified several functional/structural motifs in ATXN1 (Figure 3).”
Self-citationChong, S. S., McCall, A. E., Cota, J., Subramony, S. H., Orr, H. T., Hughes, M. R., & Zoghbi, H. Y. (1995) · Nature Genetics · doi:10.1038/ng0795-344 · Cited by 187
Self-citationTrinucleotide repeat expansion in neurological disease
Spada, A. R. L., Paulson, H. L., & Fischbeck, K. H. (1994) · Annals of Neurology · doi:10.1002/ana.410360604 · Cited by 187
Advances in Molecular Analysis of Fragile X Syndrome
Warren, S. T. (1994) · JAMA · doi:10.1001/jama.1994.03510310066040 · Cited by 204
Stévanin, G., Dürr, A., & Brice, A. (2000) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200403 · Cited by 200
Interaction between mutant ataxin-1 and PQBP-1 affects transcription and cell death.
Okazawa, H., Rich, T., Chang, A., Lin, X., Waragai, M., Kajikawa, M., Enokido, Y., Komuro, A., Kato, S., Shibata, M., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)00697-9 · Cited by 196
Recent advances in understanding the pathogenesis of Huntington's disease
Reddy, P. H., Williams, M., & Tagle, D. A. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01415-0 · Cited by 201
The complex pathology of trinucleotide repeats
Reddy, P. S., & Housman, D. E. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80009-9 · Cited by 187
Trinucleotide repeats and neurodegenerative disease
Everett, C. M. (2004) · Brain · doi:10.1093/brain/awh278 · Cited by 182
Ishikawa, K. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.7.1185 · Cited by 202
Pathways to motor incoordination: the inherited ataxias
Taroni, F., & DiDonato, S. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1474 · Cited by 207
Waragai, M. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.6.977 · Cited by 180
Ellerby, L., Hackam, A. S., Propp, S. S., Hayden, M. R., Rabizadeh, S., Cashman, N. R., Trifiro, M. A., Pinsky, L., Wellington, C. L., Salvesen, G. S., et al. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720185.x · Cited by 245
Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging
Mori, S., Crain, B. J., Chacko, V. P., & van Zijl, P. C. M. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199902)45:2 · Cited by 3,513
Long, polymorphic microsatellites in simple organisms
Field, D., & Wills, C. (1996) · Proceedings of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rspb.1996.0033 · Cited by 185
Nuclear Accumulation of Truncated Atrophin-1 Fragments in a Transgenic Mouse Model of DRPLA
Schilling, G., Wood, J., Duan, K., Slunt, H. H., Gonzales, V., Yamada, M., Cooper, J. K., Margolis, R. L., Jenkins, N. A., Copeland, N. G., et al. (1999) · Neuron · doi:10.1016/s0896-6273(00)80839-9 · Cited by 181
“…spinal and bulbar muscular atrophy and several forms of Summary spinocerebellar ataxia (The Huntington’s Disease Collaborative Research Group, 1993; Orr et al., 1993; Banfi et al., 1994; Koide et al., 1994; Nagafuchi et al., 1994b;Dentatorubral and pallidoluysian atrophy (DRPLA) is a Gusella and…”
BackgroundKang, S., Ohshima, K., Shimizu, M., Amirhaeri, S., & Wells, R. D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.27014 · Cited by 184
Klockgether, T., Skalej, M., Wedekind, D., Luft, A. R., Welte, D., Schulz, J., Abele, M., Bürk, K., Laccone, F., Brice, A., et al. (1998) · Brain : a journal of neurology · doi:10.1093/brain/121.9.1687 · Cited by 183
“…of the genes (SCA1, SCA2 andSCA3) have been isolated, and the mutations have been shown to be unstable trinucleotide (CAG) repeat expansions present within coding regions of the respective genes (Orr et al., 1993; Kawaguchiet al., 1994; Imbertet al., 1996; Pulstet al., 1996; Sanpeiet al., 1996).”
BackgroundMethodSchweitzer, J. K., & Livingston, D. M. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.1.69 · Cited by 180
Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target
Krzyżosiak, W. J., Sobczak, K., Wojciechowska, M., Fiszer, A., Mykowska, A., & Kozłowski, P. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr729 · Cited by 191
“An RNA gain-of-function mechanism by mutant CUG repeats is also implicated in SCA8 pathogenesis.”
BackgroundInfluentialMolecular and clinical studies in SCA-7 define a broad clinical spectrum and the infantile phenotype
Benton, C. S., de Silva, R., Rutledge, S. L., Bohlega, S., Ashizawa, T., & Zoghbi, H. Y. (1998) · Neurology · doi:10.1212/wnl.51.4.1081 · Cited by 172
Self-citationTang, B., Liu, C.-Y., Shen, L., Dai, H., Pan, Q., Jing, L.-J., Ouyang, S., & Xia, J. (2000) · Archives of Neurology · doi:10.1001/archneur.57.4.540 · Cited by 178
Genetic modulation of polyglutamine toxicity by protein conjugation pathways in Drosophila
Chan, H. Y. E. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.23.2895 · Cited by 165
Aggregation of N-terminal huntingtin is dependent on the length of its glutamine repeats
Li, S. H. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.5.777 · Cited by 162
Johansson, J. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.2.171 · Cited by 169
Serra, H. G., Byam, C. E., Lande, J. D., Tousey, S. K., Zoghbi, H. Y., & Orr, H. T. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh268 · Cited by 176
“Spinocerebellar ataxia type 1 (SCA1) is a neurodegenerative disease caused by the expansion of a glutamine repeat inside the disease protein, ataxin-1 ( 1 ).”
BackgroundSelf-citationTissue transglutaminase: a possible role in neurodegenerative diseases
Lesort, M. J., Tucholski, J., Miller, M. L., & Johnson, G. V. W. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00052-0 · Cited by 173
Ikeuchi, T., Koide, R., Tanaka, H., Onodera, O., Igarashi, S., Takahashi, H., Kondo, R., Ishikawa, A., Tomoda, A., Miike, T., et al. (1995) · Annals of Neurology · doi:10.1002/ana.410370610 · Cited by 168
Beyond the Qs in the polyglutamine diseases: Table 1.Preprint
Orr, H. T. (2001) · Genes & Development · doi:10.1101/gad.888401 · Cited by 168
“…of the genes affected in Huntington disease (HD; Huntington’s Disease Collaborative Research Group 1993) and spinocerebellar ataxia type 1 (SCA1; Orr et al. 1993), and subsequently with the identification of the basis for several other neurodegenerative diseases (for review, see Zoghbi and Orr…”
BackgroundSelf-citationDavies, S. W., Beardsall, K., Turmaine, M., DiFiglia, M., D, N. A. M., & Bates, G. P. (1998) · The Lancet · doi:10.1016/s0140-6736(97)08360-8 · Cited by 163
Polyglutamine neurodegenerative diseases and regulation of transcription: assembling the puzzlePreprint
Riley, B. E., & Orr, H. T. (2006) · Genes & Development · doi:10.1101/gad.1436506 · Cited by 151
“Spinocerebellar ataxia type 1 (SCA1) was the first of the autosomal dominant ataxias for which the gene was cloned (Orr et al. 1993).”
Self-citationSilveira, I., Miranda, C., Guimarães, L., Moreira, M., Alonso, I., Mendonça, P., Ferro, A., Pinto-Basto, J., Coelho, J., Ferreirinha, F., et al. (2002) · Archives of Neurology · doi:10.1001/archneur.59.4.623 · Cited by 171
Bürk, K., Fetter, M., Abele, M., Laccone, F., Brice, A., Dichgans, J., & Klockgether, T. (1999) · Journal of Neurology · doi:10.1007/s004150050456 · Cited by 171
Paulsen, J. S., Nance, M., Kim, J.-I., Carlozzi, N. E., Panegyres, P. K., Erwin, C., Goh, A., McCusker, E., & Williams, J. K. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.08.003 · Cited by 168
Abnormal gene product identified in hereditary dentatorubral–pallidoluysian atrophy (DRPLA) brain
Yazawa, I., Nukina, N., Hashida, H., Goto, J., Yamada, M., & Kanazawa, I. (1995) · Nature Genetics · doi:10.1038/ng0595-99 · Cited by 158
Yue, S. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.1.25 · Cited by 168
“Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant neurodegenerative disease caused by the expansion of a polyglutamine tract within the SCA1 product, ataxin-1 (1).”
BackgroundSelf-citationEbbert, M., Jensen, T. D., Jansen‐West, K. R., Sens, J. P., Reddy, J. S., Ridge, P. G., Kauwe, J. S. K., Belzil, V., Pregent, L., Carrasquillo, M. M., et al. (2019) · Genome biology · doi:10.1186/s13059-019-1707-2 · Cited by 205
Oculomotor phenotypes in autosomal dominant ataxias.
Buttner, N., Geschwind, D., Jen, J., Perlman, S., Pulst, S., & Baloh, R. (1998) · Archives of Neurology · doi:10.1001/archneur.55.10.1353 · Cited by 167
“The repeat expansion lies within the coding region of each SCA gene and is predicted to give rise to a polyglutamine tract.(5,23,24) Recent reports suggest that the polyglutamine tract itself acts as a common effector mechanism leading to toxic effects.”
BackgroundLaboratory Guidelines for Huntington Disease Genetic Testing
NANCE, M. A., Seltzer, W. K., Ashizawa, T., Bennett, R. L., McIntosh, N. M., Myers, R. H., Potter, N. T., & Shea, D. K. (1998) · The American Journal of Human Genetics · doi:10.1086/301846 · Cited by 165
Stevanovski, I., Chintalaphani, S., Gamaarachchi, H., Ferguson, J. M., Pineda, S. S., Scriba, C., Tchan, M. C., Fung, V. S. C., Ng, K., Cortese, A., et al. (2021) · medRxiv · doi:10.1101/2021.09.27.21263187 · Cited by 164
“Our patient cohort included one patient with SCA1, which is caused by a coding ‘CAG’ polyglutamine tract expansion (> 38 copies) within ATXN1 (81).”
BackgroundInfluentialDonato, S. D., Mariotti, C., & Taroni, F. (2011) · Handbook of clinical neurology · doi:10.1016/b978-0-444-51892-7.00025-5 · Cited by 46
“However, the correlation is broad: only 36%-70% of age-at-onset variance can be explained by CAG repeat size [Orr et al 1993, Schöls et al 1997, Stevanin et al 2000, Globas et al 2008, Whaley et al 2011, Ashizawa et al 2013, Tezenas du Montcel et al 2014a].”
Fujigasaki, H. (2001) · Brain · doi:10.1093/brain/124.10.1939 · Cited by 161
“It is known that several types of ADCA, such as spinocerebellar ataxia (SCA) 1, 2, 3, 6 and 7 (Orr et al., 1993; Kawaguchi et al., 1994; Imbert et al., 1996; Pulst et al., 1996; Sanpei et al., 1996; David et al., 1997; Zhuchenko et al., 1997), encoding polyglutamine stretches, as well as Huntington’s disease (The Hunt…”
BackgroundExercise and Genetic Rescue of SCA1 via the Transcriptional Repressor Capicua
Fryer, J. D., Yu, P., Kang, H., Mandel-Brehm, C., Carter, A. N., Crespo-Barreto, J., Gao, Y., Flora, A., Shaw, C., Orr, H. T., et al. (2011) · Science · doi:10.1126/science.1212673 · Cited by 162
“previously described and characterized (1) and these mice have been backcrossed onto”
Self-citationEarly symptoms in spinocerebellar ataxia type 1, 2, 3, and 6
Globas, C., du Montcel, S. T., Balikó, L., Boesch, S., Depondt, C., DiDonato, S., Dürr, A., Filla, A., Klockgether, T., Mariotti, C., et al. (2008) · Movement Disorders · doi:10.1002/mds.22288 · Cited by 159
Richfield, E. K., Maguire‐Zeiss, K. A., Vonkeman, H. E., & Voorn, P. (1995) · Annals of Neurology · doi:10.1002/ana.410380605 · Cited by 153
Kim, S., Jeitner, T. M., & Steinert, P. M. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(01)00064-x · Cited by 156
Benomar, A., Krols, L., Stévanin, G., Cancel‐Tassin, G., Leguern, É., David, G., Ouhabi, H., Martin, J., Dürr, A., Zaǐm, A., et al. (1995) · Nature Genetics · doi:10.1038/ng0595-84 · Cited by 160
Spinocerebellar ataxia type 1 with multiple system degeneration and glial cytoplasmic inclusions
Gilman, S., Sima, A. A. F., Junck, L., Kluin, K., Koeppe, R., Lohman, M., & Little, R. J. A. (1996) · Annals of Neurology · doi:10.1002/ana.410390214 · Cited by 157
Johnsson, L., Helgesson, G., Rafnar, T., Halldórsdóttir, I., Chia, K., Eriksson, S., & Hansson, M. (2010) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.10 · Cited by 156
Gennarino, V. A., Singh, R. K., White, J. J., Maio, A. D., Han, K., Kim, J., Jafar‐Nejad, P., di Ronza, A., Kang, H., Sayegh, L. S., et al. (2015) · Cell · doi:10.1016/j.cell.2015.02.012 · Cited by 155
“Spinocerebellar ataxia type 1 (SCA1) is paradigmatic of the subgroup of polyglutamine (polyQ) proteinopathies caused by expansion of an unstable CAG repeat in the coding region of the relevant disease gene, in this case ATAXIN1 (ATXN1) (Orr et al., 1993).”
BackgroundSelf-citationSo near yet so far: Neglect in far or near space depends on tool use
Pegna, A., Petit, L. S., Caldara-Schnetzer, A.-S., Khateb, A., Annoni, J., Sztajzel, R., & Landis, T. (2001) · Annals of Neurology · doi:10.1002/ana.10058 · Cited by 153
Retinal degeneration characterizes a spinocerebellar ataxia mapping to chromosome 3p
Gouw, L. G., Kaplan, C. D., Haines, J. H., Digre, K. B., Rutledge, S. L., Matilla‐Dueñas, A., Leppert, M., Zoghbi, H. Y., & Ptáček, L. J. (1995) · Nature Genetics · doi:10.1038/ng0595-89 · Cited by 152
Self-citationChintalaphani, S. R., Pineda, S. S., Deveson, I. W., & Kumar, K. R. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01201-x · Cited by 177
Cyclin D1: Mechanism and Consequence of Androgen Receptor Co-repressor Activity
Petre, C. E., Wetherill, Y. B., Danielsen, M., & Knudsen, K. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106399200 · Cited by 144
“Other AR co-repressors such as calreticulin and p53 oppose the activity of type 2 coactivators, respectively preventing receptor-DNA and N- to C- terminal interactions (33, 64).”
BackgroundInfluentialMolecular features of the CAG repeats of spinocerebellar ataxia 6 (SCA6)
Matsuyama, Z. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.8.1283 · Cited by 160
Tsai, C.-C., Kao, H.-Y., Mitzutani, A., Banayo, E., Rajan, H., McKeown, M., & Evans, R. (2004) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0400615101 · Cited by 147
Nonneural nuclear inclusions of androgen receptor protein in spinal and bulbar muscular atrophy.
Li, M., Nakagomi, Y., Kobayashi, Y., Merry, D., Tanaka, F., Doyu, M., Mitsuma, T., Hashizume, Y., Fischbeck, K., & Sobue, G. (1998) · American Journal of Pathology · doi:10.1016/s0002-9440(10)65612-x · Cited by 147
Ishikawa, K., Tanaka, H., Saito, M., Ohkoshi, N., Fujita, T., Yoshizawa, K., Ikeuchi, T., Watanabe, M., Hayashi, A., Takiyama, Y., et al. (1997) · The American Journal of Human Genetics · doi:10.1086/514867 · Cited by 150
“Nat Genet 6:9–13 Kwiatkowski TJ Jr, Orr HT, Banfi S, McCall AE, Jodice C,Flanigan K, Gardner K, Alderson K, Galster B, Otterud B, Leppert MF, Kaplan C, et al (1996) Autosomal dominant Persichetti F, Novelletto A, et al (1993) The gene for autosomal dominant spinocerebellar ataxia (SCA1) maps centro-spinocerebellar ata…”
BackgroundResultInfluentialTrinucleotide repeats in the human androgen receptor: a molecular basis for disease
Choong, C. S., & Em, W. (1998) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0210235 · Cited by 141
Stability of an expanded trinucleotide repeat in the androgen receptor gene in transgenic mice
Bingham, P., Scott, M., Wang, S.-P., Mcphaul, M., Wilson, E., Garbern, J., Merry, D., & Fischbeck, K. (1995) · Nature Genetics · doi:10.1038/ng0295-191 · Cited by 144
Saleem, Q., Choudhry, S., Mukerji, M., Bashyam, L., Padma, M., Chakravarthy, A., Maheshwari, M. C., Jain, S., & Brahmachari, S. (2000) · Human Genetics · doi:10.1007/s004390000240 · Cited by 143
“Repeat sizes were estimated at the SCA1, SCA2, MJD/SCA3, SCA6, SCA7, SCA8 and DRPLA loci by PCR using previously published primers (Orr et al. 1993; Kawaguchi et al. 1994; Koide et al. 1994; Pulst et al. 1996; Zuchenko et al. 1997; Gouw et al. 1998; Koob et al. 1999).”
MethodChoudhry, S., Mukerji, M., Srivastava, A., Jain, S., & Brahmachari, S. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.21.2437 · Cited by 142
Terwindt, G., Ophoff, R., Haan, J., Vergouwe, M., van Eijk, R., Frants, R., & Ferrari, M. (1998) · Neurology · doi:10.1212/wnl.50.4.1105 · Cited by 142
Hypermutable myotonic dystrophy CTG repeats in transgenic mice
Monckton, D. G., Coolbaugh-Murphy, M. I., Ashizawa, K. T., Siciliano, M. J., & Caskey, C. T. (1997) · Nature Genetics · doi:10.1038/ng0297-193 · Cited by 131
Genís, D., Matilla, T., Volpini, V., Rosell, J., Dávalos, A., Ferrer, I., Molíns, A., & Estivill, X. (1995) · Neurology · doi:10.1212/wnl.45.1.24 · Cited by 142
Gerstberger, S. C., Hafner, M., Ascano, M., & Tuschl, T. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-1221-6_1 · Cited by 154
Clinical and genetic analysis of 4 Mexican families with spinocerebellar ataxia type 10
Rasmussen, A., Matsuura, T., Ruano, L., Yescas, P., Ochoa, A., Ashizawa, T., & Alonso, E. (2001) · Annals of Neurology · doi:10.1002/ana.1081 · Cited by 141
“Identification of the causative mutations in ADCA began in 1993, with the discovery of the SCA1 mutation.(7) Expansions of polymorphic CAG/CTG repeats are mutations associated with SCA1, SCA2, SCA3, SCA6, SCA7, SCA8, and SCA12; and the genes responsible for SCA4, SCA5, SCA11, SCA13, and SCA14 have been mapped.”
BackgroundWorth, P., Giunti, P., Gardner-Thorpe, C., Dixon, P., Davis, M., & Wood, N. W. (1999) · American Journal of Human Genetics · doi:10.1086/302495 · Cited by 141
“0002-9297/99/6502-0017$02.00 109150), have been cloned (Orr et al. 1993; Kawaguchi et al. 1994; Flanigan et al. 1996; Imbert et al. 1996; Pulst et al. 1996; Sanpei et al. 1996).”
InfluentialThe Neuropathology of CAG Repeat Diseases: Review and Update of Genetic and Molecular Features
Robitaille, Y., Lopes-Cendes, Í., Becher, M., Rouleau, G., & Clark, A. W. (1997) · Brain Pathology · doi:10.1111/j.1750-3639.1997.tb00893.x · Cited by 141
Takiyama, Y., Oyanagi, S., Kawashima, S., Sakamoto, H., Saito, K., Yoshida, M., Tsuji, S., Mizuno, Y., & Nishizawa, M. (1994) · Neurology · doi:10.1212/wnl.44.7.1302 · Cited by 141
Wang, Y. H., & Griffith, J. D. (1995) · Genomics · doi:10.1016/0888-7543(95)80061-p · Cited by 140
Sobczak, K., & Krzyzosiak, W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409984200 · Cited by 138
Spinocerebellar ataxias in Spanish patients: genetic analysis of familial and sporadic cases
Pujana, M., Corral, J., Gratacòs, M., Combarros, O., Berciano, J., Genís, D., Banchs, I., Estivill, X., & Volpini, V. (1999) · Human Genetics · doi:10.1007/s004390050997 · Cited by 138
Predictive testing for Huntington disease: interpretation and significance of intermediate alleles
Semaka, A., Creighton, S., Warby, S. C., & Hayden, M. R. (2006) · Clinical Genetics · doi:10.1111/j.1399-0004.2006.00668.x · Cited by 133
“Not only will such studies be useful in the context of HD, but other trinucleotide disorders with intermediate alleles such as fragile X (59, 60), spinocerebellar ataxia 1 (61, 62), 3 (63), and 7 (64), myotonic dystrophy (65), and Friedrich’s ataxia (66, 67).”
BackgroundIkeuchi, T., Takano, H., Koide, R., Igarashi, S., Tanaka, H., Tsuji, S., Takahashi, H., Horikawa, Y., Honma, Y., Onishi, Y., et al. (1997) · Annals of Neurology · doi:10.1002/ana.410420609 · Cited by 136
Genetic background of apparently idiopathic sporadic cerebellar ataxia
Schöls, L., Szymanski, S., Peters, S., Przuntek, H., Epplen, J., Hardt, C., & Riess, O. (2000) · Human Genetics · doi:10.1007/s004390000346 · Cited by 135
Transgenic models of Huntington's disease.
Sathasivam, K., Hobbs, C., Mangiarini, L., Mahal, A., Turmaine, M., Doherty, P., Davies, S., & Bates, G. (1999) · Human Molecular Genetics · doi:10.1098/rstb.1999.0447 · Cited by 133
Cognitive deficits in spinocerebellar ataxia 2.
Bürk, K., Globas, C., Bösch, S., Gräber, S., Abele, M., Brice, A., Dichgans, J., Daum, I., & Klockgether, T. (1999) · Brain : a journal of neurology · doi:10.1093/brain/122.4.769 · Cited by 133
“Patients carrying longer CAG repeats show earlier disease onset, have faster disease progression and are often more severely affected (Orr et al., 1993; Maciel et al., 1995; Klockgetheret al., 1996).”
BackgroundLu, H., Tan, Q., Rousseaux, M. W. C., Wang, W., Kim, J., Richman, R., Wan, Y., Yeh, S.-Y., Patel, J. M., Liu, X., et al. (2017) · Nature Genetics · doi:10.1038/ng.3808 · Cited by 147
Self-citationMultiplex Families With Multiple System Atrophy
Hara, K., Momose, Y., Tokiguchi, S., Shimohata, M., Terajima, K., Onodera, O., Kakita, A., Yamada, M., Takahashi, H., Hirasawa, M., et al. (2007) · Archives of Neurology · doi:10.1001/archneur.64.4.545 · Cited by 148
Rethinking Genotype and Phenotype Correlations in Polyglutamine Expansion Disorders
Andrew, S. E., Goldberg, Y. P., & Hayden, M. R. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.12.2005 · Cited by 130
Simeoni, S. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.1.133 · Cited by 127
Protein misfolding in Alzheimer’s and Parkinson’s disease: genetics and molecular mechanisms
Forloni, G., Terreni, L., Bertani, I., Fogliarino, S., Invernizzi, R. W., Assini, A., Ribizzi, G., Negro, A., Calabrese, E., & Volonté, M. A. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00076-3 · Cited by 132
“[132] Orr HT, Chung MY, Banfi S, Kwiatkowski TJ, Servadio A, Beaudet AL, et al.”
BackgroundMagnetic stimulation over the cerebellum in patients with ataxia.
Ugawa, Y., Terao, Y., Hanajima, R., Sakai, K., Furubayashi, T., Machii, K., & Kanazawa, I. (1997) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/s0168-5597(97)00051-8 · Cited by 131
Metadata
- Authors
- Orr, H. T., Chung, M.-Y., Banfi, S., Kwiatkowski, T. J., Servadio, A., Beaudet, A. L., McCall, A. E., Duvick, L. A., Ranum, L. P. W., & Zoghbi, H. Y.
- Affiliations
- University of Minnesota (US)
- Baylor College of Medicine (US)
- Howard Hughes Medical Institute (US)
- ORCID
- Venue
- Nature Genetics
- Published
- 1993-07
- Volume
- 4
- Issue
- 3
- Pages
- 221-226
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2255469197
- Cited by
- 1,632
- References
- 0
- Citations by year
- 2026: 20 · 2025: 24 · 2024: 30 · 2023: 37 · 2022: 45 · 2021: 35 · 2020: 41 · 2019: 27 · 2018: 42 · 2017: 35 · 2016: 23 · 2015: 19 · 2014: 41 · 2013: 50 · 2012: 34
- FWCI
- 40.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- spinocerebellar ataxia type 1, CAG repeat expansion, trinucleotide repeat instability, age of onset, chromosome 6, repeat polymorphism, mRNA transcripts, neurodegeneration
- MeSH terms
- Base Sequence, Chromosome Mapping, Chromosomes, Human, Pair 6, Cloning, Molecular, DNA, Female, Humans, Male, Molecular Sequence Data, Oligodeoxyribonucleotides, Pedigree, Repetitive Sequences, Nucleic Acid, Spinocerebellar Degenerations, Transcription, Genetic, Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review